APTABIO THERAPEUTICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,000 KRW | -0.33% |
|
-5.66% | -33.70% |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 237,483 | 201,805 |
| Enterprise Value (EV) 1 | 220,834 | 162,853 |
| P/E ratio | -22.5 x | -17 x |
| Yield | - | - |
| Capitalization / Revenue | 4,911 x | 623 x |
| EV / Revenue | 4,567 x | 503 x |
| EV / EBITDA | -24.5 x | -9.95 x |
| EV / FCF | - | -12,154,636 x |
| FCF Yield | - | -0% |
| Price to Book | 4.53 x | 3.54 x |
| Nbr of stocks (in thousands) | 22,299 | 22,299 |
| Reference price 2 | 10,650 | 9,050 |
| Announcement Date | 19/03/24 | 19/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Net sales 1 | 48.35 | 323.9 |
| EBITDA 1 | -9,022 | -16,364 |
| EBIT 1 | -9,507 | -16,904 |
| Operating Margin | -19,661.23% | -5,219.25% |
| Earnings before Tax (EBT) 1 | -10,565 | -14,692 |
| Net income 1 | -10,565 | -12,062 |
| Net margin | -21,849.26% | -3,724.24% |
| EPS 2 | -474.0 | -532.0 |
| Free Cash Flow | - | -13,398 |
| FCF margin | - | -4,137% |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 19/03/24 | 19/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Net Debt 1 | - | - |
| Net Cash position 1 | 16,649 | 38,951 |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | -13,398 |
| ROE (net income / shareholders' equity) | - | -21.2% |
| ROA (Net income/ Total Assets) | - | -14.2% |
| Assets 1 | - | 84,847 |
| Book Value Per Share 2 | 2,349 | 2,557 |
| Cash Flow per Share 2 | 89.20 | 1,051 |
| Capex 1 | 1,041 | 1,345 |
| Capex / Sales | 2,152.54% | 415.27% |
| Announcement Date | 19/03/24 | 19/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -33.70% | 98.36M | |
| +2.97% | 108B | |
| +10.21% | 105B | |
| +1.57% | 23.46B | |
| -12.77% | 21.72B | |
| -7.05% | 18.64B | |
| -37.64% | 17.45B | |
| -6.50% | 17.19B | |
| +6.00% | 13.99B | |
| +37.20% | 12.53B |
- Stock Market
- Equities
- A293780 Stock
- Financials AptaBio Therapeutics Inc.
